Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. TC BioPharm (Holdings) plc ADR’s current trading price is -99.57% away from its 52-week high, while its distance from the 52-week low is 7.64%. The stock’s price range over this period has fluctuated between $0.56 and $138.00. The company, operating within the financial sector, had a trading volume of approximately 0.5 million for the day, which was noticeably lower than the average daily share volume of 1.23 million over the last 3 months.
In terms of market performance, TC BioPharm (Holdings) plc ADR had a fairly uneven. The highest value for the stock in the past year was $138.00 on 11/28/23, and the lowest value was recorded at $0.56 on 11/15/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
TC BioPharm (Holdings) plc ADR (TCBP) has experienced a quarterly decline of -88.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 0.29M and boasts a workforce of 41 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.6534, with a change in price of -7.9040. Similarly, TC BioPharm (Holdings) plc ADR recorded 815,741 in trading volume during the last 100 days, posting a change of -92.94%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TCBP stands at 0.83. Similarly, the long-term debt-to-equity ratio is also 0.67.
TCBP Stock Stochastic Average
Today, TC BioPharm (Holdings) plc ADR’s raw stochastic average for the past 50 days stands at 0.55%, indicating a decline from the raw stochastic average of the last 20 days, which was 4.38%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 6.74% and 6.66% respectively.
TCBP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded a decrease of -98.11%. However, over the last six months, the performance has been stronger by -94.37%. The price of TCBP decreased -62.96% over the last 30 days. And in the last five days, it has fallen by -4.76%.
